Eton Pharmaceuticals, Inc. · NASDAQ:ETON
The Vanguard Group reported a 5.01% stake in Eton Pharmaceuticals, Inc. (Schedule 13G)
Event Sep 30, 2025 · Filed Oct 30, 2025
The Vanguard Group reported a 5.01% stake in Eton Pharmaceuticals, Inc., 1,344,115 shares, as a passive investor on Sep 30, 2025. Filed Oct 30, 2025 (Schedule 13G).
- Stake
- 5.01%
- Shares
- 1,344,115
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 5.01% | 1,344,115 |
Source
Related
- Eton Pharmaceuticals, Inc.
- The Vanguard Group
- Eton Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · The Vanguard Group · Mar 26, 2026
- Form 4 · Krempa David · Oct 6, 2026
- Form 4/A · Maier Paul V · Aug 31, 2026
- Form 4 · Krempa David · Aug 24, 2026
- Form 4 · Brynjelsen Sean · Aug 20, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 28, 2026